Opioid Treatment Program Information for Providers

Division of Pharmacologic Therapies

SAMHSA’s Division of Pharmacologic Therapies (DPT) works to oversee and facilitate treatment for substance use disorders. DPT, part of SAMHSA’s Center for Substance Abuse Treatment (CSAT), manages the day-to-day oversight activities necessary to implement federal regulations on the use of substance use disorder medications such as methadone and buprenorphine for the treatment of opioid use disorder (OUD). DPT supports the certification and accreditation of more than 1,900 opioid treatment programs (OTPs) that collectively treat more than 600,000 patients each year.

Contact DPT

240-276-2700

DPT@samhsa.hhs.gov

Find Information

###
[
Become an Opioid Treatment Program (OTP)
](https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/become-otp)

To provide services for opioid use disorder patients, OTPs must successfully complete the certification and accreditation process and meet other requirements outlined in 42 CFR 8.

###
[
State Opioid Treatment Authorities
](https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/sota)

A listing of State Opioid Treatment Authorities (SOTA) by state in alphabetical order.

###
[
42 CFR Part 8 Final Rule
](https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/42-cfr-part-8)

Part 8 of Title 42 of the Code of Federal Regulations (CFR) includes the regulations that guide opioid treatment programs (OTPs); these went into effect in 2001. HHS, through the SAMHSA, revised these regulations and released the final rule in February 2024.

###
[
Submit an Opioid Treatment Exception Request
](https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/exception-request)

Any deviation from the opioid treatment standards in 42 CFR 8 requires the submission and approval of the Form SMA-168 exception request.

###
[
Take-Home Extension Guidance
](https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/methadone-guidance)

The duration of this exemption shall be for the period of one year from the end of the COVID-19 Public Health Emergency, or until such time that final rules revising 42 C.F.R. part 8 are published by the U.S. Department of Health and Human Services, whichever occurs sooner.

###
[
Notify SAMHSA of Program Changes
](https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/program-changes)

Per federal regulations opioid treatment programs (OTPs) must notify SAMHSA of changes to their existing program by logging into the SAMHSA OTP Extranet and submitting the online Form SMA-162: Application for Certification to Use Opioid Drugs in a Treatment Program.

###
[
Approved Accreditation Bodies
](https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/accreditation-bodies)

SAMHSA-approved accrediting bodies work to ensure that OTPs meet specific, nationally accepted standards for providing medications for substance use disorders.

###
[
Request TTA
](mailto:otpta@manhattanstrategy.com)

SAMHSA provides free training and technical assistance (TTA) to OTPs, OTP staff, SOTAs, and related organizations on the implementation of the updated requirements in 42 CFR part 8 regulations and related SAMHSA certification and accreditation standards. The TTA for OTPs is designed to ensure the expansion of and improved access to treatment, strengthen the patient-practitioner relationship through shared and evidence-based decision making; enhance integration of services and care coordination. TTA is available to OTPs in various formats such as on-site and off-site training, TA consultation, and virtual workshops.

Related Pages

Opioid Treatment Program (OTP) Compliance Officers

Federal Statutes, Regulations, and Guidelines

Provider Information on Treatment Options

Training Requirements (MATE Act) Resources

Practitioner Training Materials and Resources

Buprenorphine Quick Start Guide (PDF | 1.4 KB)

Buprenorphine Pocket Guide (PDF | 200 KB)

Federal Register: Buprenorphine Guidelines for Prescribing Practitioners

Where this page came from

This page was imported from Substance Abuse and Mental Health Services Administration. Published by the Substance Abuse and Mental Health Services Administration and, as a work of the United States government, in the public domain; material credited to others is left out.

Nobody has written it yet — it is the source material at a new address, which is why search engines are asked to skip it and why no one earns from it. It is up for grabs: take it on, and it is yours to rewrite and to earn from.